BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18656455)

  • 1. Renal protection by 3H-1,2-dithiole-3-thione against cisplatin through the Nrf2-antioxidant pathway.
    Park HM; Cho JM; Lee HR; Shim GS; Kwak MK
    Biochem Pharmacol; 2008 Sep; 76(5):597-607. PubMed ID: 18656455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Nrf2-regulated genes by 3H-1, 2-dithiole-3-thione through the ERK signaling pathway in murine keratinocytes.
    Manandhar S; Cho JM; Kim JA; Kensler TW; Kwak MK
    Eur J Pharmacol; 2007 Dec; 577(1-3):17-27. PubMed ID: 17854798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of cellular glutathione by 3H-1,2-dithiole-3-thione as a possible treatment strategy for protecting against acrolein-induced neurocytotoxicity.
    Jia Z; Misra BR; Zhu H; Li Y; Misra HP
    Neurotoxicology; 2009 Jan; 30(1):1-9. PubMed ID: 19073213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo modulation of the Parkinsonian phenotype by Nrf2.
    Burton NC; Kensler TW; Guilarte TR
    Neurotoxicology; 2006 Dec; 27(6):1094-100. PubMed ID: 16959318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione.
    Kwak MK; Itoh K; Yamamoto M; Sutter TR; Kensler TW
    Mol Med; 2001 Feb; 7(2):135-45. PubMed ID: 11471548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidants and phase 2 enzymes in macrophages: regulation by Nrf2 signaling and protection against oxidative and electrophilic stress.
    Zhu H; Jia Z; Zhang L; Yamamoto M; Misra HP; Trush MA; Li Y
    Exp Biol Med (Maywood); 2008 Apr; 233(4):463-74. PubMed ID: 18367636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: protection against reactive oxygen and nitrogen species-induced cell injury.
    Zhu H; Itoh K; Yamamoto M; Zweier JL; Li Y
    FEBS Lett; 2005 Jun; 579(14):3029-36. PubMed ID: 15896789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of endogenous glutathione by the chemoprotective agent, 3H-1,2-dithiole-3-thione, in human neuroblastoma SH-SY5Y cells affords protection against peroxynitrite-induced cytotoxicity.
    Cao Z; Hallur S; Qiu HZ; Peng X; Li Y
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1043-9. PubMed ID: 15044090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of endogenous glutathione system by 3H-1,2-dithiole-3-thione in pancreatic RINm5F beta-cells as a novel strategy for protecting against oxidative beta-cell injury.
    Zhu H; Zhang L; Trush MA; Li Y
    Free Radic Res; 2007 Feb; 41(2):242-50. PubMed ID: 17364951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of 3H-1, 2-dithiole-3-thione on cellular model of Alzheimer's disease involves Nrf2/ARE signaling pathway.
    Wang L; Wang M; Hu J; Shen W; Hu J; Yao Y; Wang X; Afzal CM; Ma R; Li G
    Eur J Pharmacol; 2017 Jan; 795():115-123. PubMed ID: 27939991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential roles of 3H-1,2-dithiole-3-thione-induced glutathione, glutathione S-transferase and aldose reductase in protecting against 4-hydroxy-2-nonenal toxicity in cultured cardiomyocytes.
    Li Y; Cao Z; Zhu H; Trush MA
    Arch Biochem Biophys; 2005 Jul; 439(1):80-90. PubMed ID: 15946642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 controls bone marrow stromal cell susceptibility to oxidative and electrophilic stress.
    Zhu H; Zhang L; Itoh K; Yamamoto M; Ross D; Trush MA; Zweier JL; Li Y
    Free Radic Biol Med; 2006 Jul; 41(1):132-43. PubMed ID: 16781461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor E2-related factor 2-dependent myocardiac cytoprotection against oxidative and electrophilic stress.
    Zhu H; Jia Z; Misra BR; Zhang L; Cao Z; Yamamoto M; Trush MA; Misra HP; Li Y
    Cardiovasc Toxicol; 2008; 8(2):71-85. PubMed ID: 18463988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells.
    Kim SJ; Park C; Han AL; Youn MJ; Lee JH; Kim Y; Kim ES; Kim HJ; Kim JK; Lee HK; Chung SY; So H; Park R
    Hear Res; 2009 May; 251(1-2):70-82. PubMed ID: 19286452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of nuclear factor (erythroid-2 like) factor 2 by toxic bile acids provokes adaptive defense responses to enhance cell survival at the emergence of oxidative stress.
    Tan KP; Yang M; Ito S
    Mol Pharmacol; 2007 Nov; 72(5):1380-90. PubMed ID: 17724089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of Nrf2 protein by D3T provides protection against ethanol-induced apoptosis in PC12 cells.
    Dong J; Yan D; Chen SY
    PLoS One; 2011 Feb; 6(2):e16845. PubMed ID: 21304811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological activation of the Nrf2 pathway by 3H-1, 2-dithiole-3-thione is neuroprotective in a mouse model of Alzheimer disease.
    Cui Y; Ma S; Zhang C; Li D; Yang B; Lv P; Xing Q; Huang T; Yang GL; Cao W; Guan F
    Behav Brain Res; 2018 Jan; 336():219-226. PubMed ID: 28887195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinated upregulation of a series of endogenous antioxidants and phase 2 enzymes as a novel strategy for protecting renal tubular cells from oxidative and electrophilic stress.
    Zhu H; Zhang L; Amin AR; Li Y
    Exp Biol Med (Maywood); 2008 Jun; 233(6):753-65. PubMed ID: 18408143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the Nrf2-proteasome pathway in the endoplasmic reticulum stress response in pancreatic β-cells.
    Lee S; Hur EG; Ryoo IG; Jung KA; Kwak J; Kwak MK
    Toxicol Appl Pharmacol; 2012 Nov; 264(3):431-8. PubMed ID: 22959925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance.
    Cho JM; Manandhar S; Lee HR; Park HM; Kwak MK
    Cancer Lett; 2008 Feb; 260(1-2):96-108. PubMed ID: 18036733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.